What is the price target for TLSA stock?
7 analysts have analysed TLSA and the average price target is 8.16 USD. This implies a price increase of 568.85% is expected in the next year compared to the current price of 1.22.
TIZIANA LIFE SCIENCES LTD (TLSA) Forecast, Price Target & Analyst Ratings
NASDAQ:TLSA • BMG889121031
Current stock price
1.22 USD
-0.04 (-3.17%)
At close:
1.21 USD
-0.01 (-0.82%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TIZIANA LIFE SCIENCES LTD (TLSA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.16
Upside
+ 568.85%
From current price of $1.22 to mean target of $8.16, Based on 7 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for TLSA. The average price target is 8.16 USD. This implies a price increase of 568.85% is expected in the next year compared to the current price of 1.22.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
TLSA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TLSA.
In the previous month the buy percentage consensus was at a similar level.
TLSA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-13 | ThinkEquity | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 58.17% | N/A 42.83% | N/A 32.49% | ||||||||||
| EBITDA YoY % growth | N/A | -9.832M | -10.609M -7.90% | -9.84M 7.25% | -9.67M 1.73% | -30.27M -213.03% | -27.23M 10.04% | -14.54M 46.60% | -17.888M -23.03% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.16M | -9.84M 25.23% | -10.62M -7.93% | -9.86M 7.16% | -9.92M -0.61% | -30.36M -206.05% | -27.37M 9.85% | -14.59M 46.69% | -17.984M -23.26% | N/A -93.97% | N/A 33.92% | N/A -23.89% | N/A -76.88% | N/A 116.10% | N/A 1,088.67% | N/A 96.32% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A -1,900.00% | N/A -990.69% | N/A 81.48% | N/A -118.05% | N/A -223.73% | N/A -162.08% | N/A 59.46% | N/A 13.33% | N/A -38.46% | N/A -11.11% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TIZIANA LIFE SCIENCES LTD / TLSA Forecast FAQ
Can you provide the consensus rating for TIZIANA LIFE SCIENCES LTD stock?
The consensus rating for TIZIANA LIFE SCIENCES LTD (TLSA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.